Global Markets Direct’s, ‘Sarcopenia - Pipeline Review, H1 2019’, provides an overview of the Sarcopenia pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Sarcopenia, complete wit...
Global Markets Direct’s, ‘Degenerative Disc Disease - Pipeline Review, H1 2019’, provides an overview of the Degenerative Disc Disease pipeline landscape.
The report provides comprehensive information on the therapeutics under developmen...
Global Markets Direct’s, ‘Inclusion Body Myositis (IBM) - Pipeline Review, H2 2018’, provides an overview of the Inclusion Body Myositis (IBM) pipeline landscape.
The report provides comprehensive information on the therapeutics under de...
Global Markets Direct’s, ‘Muscle Atrophy - Pipeline Review, H2 2018’, provides an overview of the Muscle Atrophy pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Muscle Atrophy, ...
Global Markets Direct’s, ‘Achondroplasia - Pipeline Review, H2 2018’, provides an overview of the Achondroplasia pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Achondroplasia, ...
Global Markets Direct’s, ‘Bone Fracture - Pipeline Review, H2 2018’, provides an overview of the Bone Fracture pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Bone Fracture, com...
Global Markets Direct’s, ‘Systemic Idiopathic Juvenile Arthritis - Pipeline Review, H2 2018’, provides an overview of the Systemic Idiopathic Juvenile Arthritis pipeline landscape.
The report provides comprehensive information on the the...
Global Markets Direct’s, ‘Osteoarthritis - Pipeline Review, H2 2018’, provides an overview of the Osteoarthritis pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Osteoarthritis, ...
Global Markets Direct’s, ‘Prosthetic joint infections - Pipeline Review, H1 2018’, provides an overview of the Prosthetic joint infections pipeline landscape.
The report provides comprehensive information on the therapeutics under develo...
Global Markets Direct’s, ‘Fibrodysplasia Ossificans Progressiva (Myositis Ossificans Progressiva) - Pipeline Review, H1 2018’, provides an overview of the Fibrodysplasia Ossificans Progressiva (Myositis Ossificans Progressiva) pipeline landscap...
Global Markets Direct’s, ‘Psoriatic Arthritis - Pipeline Review, H1 2018’, provides an overview of the Psoriatic Arthritis pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Psoria...
Global Markets Direct’s, ‘Axial Spondyloarthritis - Pipeline Review, H1 2018’, provides an overview of the Axial Spondyloarthritis pipeline landscape.
The report provides comprehensive information on the therapeutics under development fo...
Global Markets Direct’s, ‘Gouty Arthritis (Gout) - Pipeline Review, H1 2018’, provides an overview of the Gouty Arthritis (Gout) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for ...
Global Markets Direct’s, ‘Pigmented Villonodular Synovitis - Pipeline Review, H1 2018’, provides an overview of the Pigmented Villonodular Synovitis pipeline landscape.
The report provides comprehensive information on the therapeutics un...
Global Markets Direct’s, ‘Muscular Dystrophy - Pipeline Review, H1 2018’, provides an overview of the Muscular Dystrophy pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Muscular...